Gérard Lledo
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 82
- Colorectal Cancer Treatments and Studies 66
- Cancer Treatment and Pharmacology 39
- Pancreatic and Hepatic Oncology Research 16
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Co-authors
- Thierry AndréAimery de GramontChristophe LouvetChristophe TournigandMarc BuysePhilippe ColinEmmanuel QuinauxEmmanuel Achille
In The Last Decade
Gérard Lledo
97 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 5.8k
- Hepatology 1.6k
- Pulmonary and Respiratory Medicine 2.3k
- Cancer Research 652
- Pathology and Forensic Medicine 712
Countries citing papers authored by Gérard Lledo
This map shows the geographic impact of Gérard Lledo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérard Lledo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérard Lledo more than expected).
Fields of papers citing papers by Gérard Lledo
This network shows the impact of papers produced by Gérard Lledo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérard Lledo. The network helps show where Gérard Lledo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gérard Lledo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 5 | |
| 2 | 2017 | 4 | |
| 3 | 2016 | 1 | |
| 4 | 2016 | 13 | |
| 5 | 2015 | 10 | |
| 6 | Pharmacogenetic tailoring of irinotecan-based first-line chemotherapy in metastatic colorectal cancer: results of a pilot study. | 2011 | 14 |
| 7 | 2010 | 20 | |
| 8 | 2009 | 262 | |
| 9 | 2009 | 2 | |
| 10 | 2009 | 10 | |
| 11 | 2008 | 41 | |
| 12 | 2007 | 68 | |
| 13 | 2007 | 24 | |
| 14 | Traitement adjuvant du cancer du côlon : principaux résultats de l’étude MOSAIC* | 2006 | 1 |
| 15 | 2006 | 24 | |
| 16 | 2006 | 35 | |
| 17 | 2005 | 13 | |
| 18 | FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study Hit paper breakdown → | 2003 | 2290 |
| 19 | Síndrome de Waardenburg. Aportación de una familia. | 1975 | 1 |
| 20 | Dos casos de síndrome de Hanhart. Uno de ellos con anorquia | 1973 | 1 |
About Gérard Lledo
Gérard Lledo is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Cancer Research and Gastroenterology, having authored 101 papers that have together received 6.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (66 papers), Cancer Treatment and Pharmacology (39 papers), Gastric Cancer Management and Outcomes (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Pancreatic and Hepatic Oncology Research (16 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal and Anal Carcinomas (10 papers). The work is most often cited by research in Oncology (5.8k citations), Hepatology (1.6k citations), Pulmonary and Respiratory Medicine (2.3k citations), Cancer Research (652 citations) and Pathology and Forensic Medicine (712 citations). Gérard Lledo has collaborated with scholars based in France, Spain and Belgium. Frequent co-authors include Thierry André, Aimery de Gramont, Christophe Louvet, Christophe Tournigand, Marc Buyse, Philippe Colin, Emmanuel Quinaux, Emmanuel Achille, G. Ganem and C. Couteau. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.